- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This paper studies 8× in-plane CT super-resolution with vascular anatomical guidance. VascuSR combines a slice-wise ResShift backbone, a frozen VSNet segmenter, a separately trained 3D rectified-flow refiner, and a lightweight mask controller. Refined vessel masks condition further SR passes. Experiments on re-annotated MSD and HVM, with an ImageCAS extension, report improved vessel overlap and structural metrics over the evaluated baselines, while image quality stays close to ResShift.
Critical strengths
(1)The problem and the separation of anatomy from appearance are well motivated. Learning vascular correction in 3D label space, while keeping HR-supervised image reconstruction, is a reasonable way to use volumetric information in slice-wise SR. The comparison with segmentation-loss fine-tuning is also relevant to this design choice. (2)Structural gains appear on both hepatic datasets, not only selected examples. Against ResShift, class-averaged component counts fall by about 21% on MSD and 33% on HVM. The zero-mask control and Appendix B are valuable here: regional intensity errors and the TotalSegmentator check provide evidence beyond the feedback segmenter's Dice.
Critical weaknesses
(1)The zero-mask ablation supports the use of anatomical conditioning, but does not tell me why the proposed 3D flow refiner is preferable to a simpler correction model. There is no raw-VSNet-mask conditioning control, no deterministic 3D refiner with the same probability input, and no N=1 versus N=8 comparison. The accuracy of the refined masks themselves is also not reported. The benefit of mask conditioning is therefore hard to separate from generative refinement and trajectory aggregation. This is the main issue in my assessment of the method. (2)The novelty appears incremental given the present evidence. Section 2.2 cites DSDM (Chu et al.) and the dual-guidance CT SR method of Chi et al., but neither appears in the experiments. SegSR (Xiao et al.) is also relevant because it exchanges updated information between segmentation and SR diffusion models. VascuSR’s explicit 3D label-space refinement and outer feedback loop are meaningful differences; I do not regard these methods as equivalent. Still, the paper does not establish what additional capability this particular design provides over existing structural guidance or mutual refinement. (3)The public datasets, patient-level partitions and optimizer settings are positive. However, the HR-to-LR degradation operator is not specified. Appendix A.1 uses refined labels from SR images during from-scratch SR/controller training, without identifying which SR model produces these images or whether the conditions are updated during training. The origin of the imperfect predictions used to train the refiner also needs clarification. The value and selection of lambda in Eq. 11 are missing for the key fine-tuning baseline. A further clarification is whether A.1’s VQ-f4-based LPIPS reference applies only to training or also to evaluation. These details affect both reproduction and the interpretation of the comparison. (4) Most structural measurements use VSNet, which also participates in feedback. The manual reference labels and the TotalSegmentator check mean that the evaluation is not simply circular. Still, the independent check covers only MSD Dice and has an acknowledged coverage mismatch. The aggregate structural results do not separately show missed branches, spurious branches and wrong connections. Table 2 also lacks a VSNet-on-HR structural reference, although Table 1 provides the overlap reference. I would like stronger evidence that the gains reflect correct vessel recovery, rather than mainly improved compatibility with the feedback segmenter. (5)The first feedback update does show a useful gain.On MSD, however, HV Dice changes from 0.7077 at round 1 to 0.7072 at round 3, while PV clDice improves from 0.5158 to 0.5286. Table 3 implies about 141 seconds for the first-feedback output and 380 seconds for K=3. Thus, some later gains exist, but their value is not clear relative to the extra cost. I do not require monotonic improvement or real-time inference. I need a clearer validation-based choice of K and evidence that updating the condition helps beyond the first round. (6) Quality results are reported without patient-level confidence intervals or variation over sampling seeds. The hepatic test sets contain 30 and 29 patients. Some comparisons are close: on MSD, HV Dice is 0.7072 versus 0.7010 for segmentation-loss fine-tuning; on HVM, round 1 to round 2 changes PV Dice from 0.7113 to 0.7117. These examples do not invalidate the larger structural gains. However, without uncertainty estimates I cannot tell which smaller differences and iteration choices are stable. Repeated inference and paired patient-level analysis would be more informative than additional decimal places. (7) I would not make tumor detection a major requirement for a vascular SR paper. Still, the refiner corrects vessel probabilities without directly seeing CT intensities, and its output guides reconstruction of the CT volume. There is no targeted analysis of disease-related vessel changes or lesions near vessels. Average vessel metrics leave this boundary of applicability open. I would value an audit of true narrowing, occlusion or tumor-related vessel deformation where such cases are available. This is a limited validation gap, not evidence that VascuSR erases pathology.
Questions for authors
(1)With matched input information, training data and controller capacity, how do raw VSNet-mask conditioning and a deterministic 3D refiner compare with FlowSeg3D? Please also compare N=1 with N=8 using appropriately validated decoding settings, and report the refined mask’s Dice/clDice before it is passed to SR. How much of that improvement transfers to the final reconstructed image? (2)Can you compare with one representative structure-guided CT SR method, such as DSDM or the method of Chi et al., using the same degradation and comparable tuning? Please also explain the methodological difference from SegSR’s mutual refinement. Which benefit is specific to the explicit 3D refiner and outer loop? If a direct implementation is not feasible, a comparable matched control could address the same question. (3)Please specify the degradation operator, the generation and update schedule of controller-training conditions, the source of refiner-training predictions, and lambda in Eq. 11. Does the VQ-f4 LPIPS reference describe the training loss only? What reference is used for each reported LPIPS result? Please provide patient-ID splits and executable configurations or pseudocode, and clarify the availability of component checkpoints and code. (4)Can you add a VSNet-on-HR row to Table 2 and an independent structural check on common annotated coverage, using another segmenter or a blinded review? Please separate centerline precision and recall and audit false connections for ResShift, the fine-tuning baseline and VascuSR. Do the structural improvements remain when evaluation is not mainly tied to VSNet? (5)How was K selected on each validation set, and which metric determined the choice? Please compare K=1 with the selected K in both quality and total runtime. A fixed-condition repeated-sampling control, with the SR sampling budget matched, would help distinguish the value of updated anatomy from sampling variation. (6)Please report paired patient-level confidence intervals for the principal method differences and variation across several inference seeds, especially for Tables 1, 2, 5 and 6. Are the smaller advantages over fine-tuning and over round 1 stable? Please distinguish uncertainty across patients and inference seeds from variability across independently trained models. (7)Among the existing held-out cases, have you checked whether documented disease-related vessel changes remain after feedback? A targeted abnormal-vessel audit would address the current anatomical claim. As an optional extension, the HVM dataset paper describes tumor masks: where these are available for the selected cases, a local lesion-fidelity or visibility assessment would help characterize non-target changes. Please otherwise state clearly that lesion preservation has not been established.
4 comments
(4) Structural validation independent of VSNet
We have added the VSNet-on-HR reference to Table 2. On MSD, VascuSR produces fewer predicted components than VSNet applied to HR images. This may reflect the framework’s emphasis on vascular continuity, together with limitations of the segmentation evaluator, which can produce fragmented predictions even on HR images.
We also added independent nnU-Net evaluation on HVM (Table 10, Appendix A.4). Relative to ResShift, VascuSR improves HV/PV Dice and clDice scores, while reducing mean centerline distance by approximately 17.3%/9.8%. The paired 95% confidence intervals for these differences exclude zero. Although the magnitude of improvement varies between evaluators, the independent evaluation reproduces the direction of the VSNet-based gains.
We additionally evaluate missed branches and disconnected false positives against manual annotations (Table 12, Appendix A.6). Compared with ResShift, VascuSR has fewer missed branches, higher mean branch recall at both coverage thresholds, and fewer zero-overlap predicted components across all four dataset–vessel combinations. Together with the component statistics in Table 2, these results support reduced fragmentation accompanied by better branch preservation.
(5) Selection of , runtime
We address the selection of and the rationale for multiple rounds in General Responses G2 and G1, respectively.
Wall-clock runtime varies with hardware and GPU workload. Under a fixed configuration, each additional round repeats the same segmentation, refinement, and SR stages, so computational cost grows approximately linearly with . Our runtime measurements indicate approximately two minutes per patient per feedback round (Table 3).
(6) Patient-level uncertainty and inference variability
Table 14 in Appendix A.8 reports paired patient-level confidence intervals for VascuSR relative to ResShift. All reported Dice and clDice difference intervals exclude zero in favor of VascuSR. Table 13 reports the mean, sample standard deviation, and win counts across five inference runs against segmentation-loss fine-tuning. VascuSR wins nearly all comparisons, with two losses in MSD HV Dice and one in MSD HV clDice. Also, our conclusions do not rely on Dice alone: Appendix B details the limitations of direct segmentation-loss fine-tuning in local image fidelity and vascular structure.
These inference experiments keep the model weights and final anatomical conditions fixed and assess variability in the final SR sampling stage. Together, the results provide evidence of consistency across patient resampling and the tested inference settings.
Regarding gains beyond the first round, the validation and test results show broadly similar trends: R1 provides most of the improvement, while later gains in Dice and clDice are smaller (Tables 5, 6, and 8). Table 9 additionally shows reductions in connected-component counts and mean centerline distances from R1 to the selected final rounds on both datasets. The consistent trends across validation and test sets, together with improvements in structural metrics, suggest that the gains from additional feedback rounds are not merely isolated sampling fluctuations.
(7) Preservation of disease-related vascular changes and lesions
We agree that preservation of disease-related vascular changes requires dedicated clinical assessment. We currently lack access to clinical experts and a suitable dataset with clinically verified abnormal-vessel annotations for this evaluation. We would welcome suggestions for publicly available resources that could support such an assessment.
Preservation of disease-related vascular changes and lesions has therefore not yet been established. We regard targeted abnormal-vessel evaluation and lesion-local fidelity assessment as important directions for future work.
Thank you for the responses and additional experiments. The simpler-refiner comparison, independent nnU-Net evaluation, and statistical analysis address several of my earlier concerns and strengthen the paper.
However, I still see the novelty as incremental. The deterministic refiner retains much of the benefit, so the extra value of generative refinement and multiple-trajectory aggregation remains unclear. Later feedback rounds provide some structural gains, but their benefit relative to the added cost and their stability across the full pipeline still need stronger evidence. I recognize that the work is solid overall, but these additions have not changed my main assessment. Therefore, I maintain my original rating.
Thank you for your follow-up and for recognizing that our work is solid overall. However, we believe there may still be a misunderstanding regarding the central contribution of our work and we would therefore like to clarify this point.
As emphasized in our contribution statement, we first “introduce explicit 3D vascular representations as anatomical guidance” for slice-wise CT super-resolution. Correcting fine vascular structures directly in image space is challenging because they are intertwined with complex tissue appearance. Extracting these structures into an explicit 3D representation allows anatomical correction to focus on vascular geometry and continuity, making the task accessible to a relatively lightweight network.
Our second contribution is the refinement–conditioning mechanism that brings these 3D corrections back into image reconstruction. Appendix B further explains the motivation for separating anatomical correction from HR-supervised image reconstruction, including the limitations observed when directly fine-tuning the generator with segmentation losses.
We recognize that our presentation of FlowSeg3D may not have sufficiently distinguished these framework-level contributions from the particular refiner used to implement them. Our central claim is not that anatomical correction must use rectified flow. The deterministic refiner retaining much of the benefit supports the broader applicability of the proposed design: the same separation of vascular correction and image reconstruction can provide effective guidance with different refiner architectures. We therefore view this result as supporting the framework’s flexibility, while clarifying the scope of the contribution.
(1) Raw-mask conditioning, deterministic refinement, and FlowSeg3D
Our main contribution is anatomical correction in vessel-label space, where vascular structures can be processed separately from complex tissue appearance using a relatively lightweight 3D network. Tables 5 and 6 in Appendix A.2 show limited improvements from raw VSNet-mask conditioning. Table 7 further reports mask Dice and clDice before and after FlowSeg3D refinement at each round, evaluated directly against manual annotations. We additionally trained a deterministic residual regression refiner using the same 3D U-Net architecture as FlowSeg3D. Both refiners improve mask quality before SR conditioning: FlowSeg3D achieves higher Dice for both vessel classes and higher HV clDice, while deterministic regression achieves higher PV clDice. Deterministic refinement also retains much of the subsequent SR benefit (Table 15, Appendix A.9), supporting the framework’s applicability across different refiner designs.
Preliminary tests showed limited refinement performance with N=1, so we did not proceed with joint SR/controller training using this configuration. The deterministic results provide a practical alternative that requires no trajectory aggregation or choice of N, while retaining effective anatomical guidance.
(2) Comparison with structure-guided SR and distinction from SegSR
Please see General Response G3 for our DSDM reproduction and discussion of a matched comparison.
SegSR exchanges information between image and segmentation diffusion branches through a Dual-Modality Bridge during individual reverse-diffusion steps. VascuSR instead completes an SR reconstruction, extracts volumetric vessel predictions, refines them with a separately trained 3D model, and supplies the updated anatomical condition to the next complete SR pass. The distinction lies in explicit volumetric refinement in vessel-label space and feedback between complete SR passes. SegSR
(3) Training, evaluation, and reproducibility details
The LR inputs were generated by clipping CT intensities to [−1000,600] HU for MSD and [−40,160] HU for HVM, linearly mapping them to [0,255], and converting them to 8-bit images. Each axial slice was then downsampled from 512×512 to 64×64 using the PIL bicubic interpolation operator. No additional noise, blur, or JPEG corruption was introduced, and no through-plane downsampling was applied.
The three controller-training condition types and their sampling probabilities are described in Appendix A.1. These conditions were generated offline and cached, then sampled during training rather than regenerated as the model parameters changed. To train the refiner, we applied VSNet to reconstructions produced by the baseline SR model and used the resulting vessel probabilities as inputs, with manual vessel annotations as targets. During joint SR/controller training, the model receives the LR image and a sampled anatomical mask condition and learns to reconstruct the corresponding HR image.
We initially explored segmentation-loss fine-tuning as a primary approach and tested multiple hyperparameter configurations. The reported settings are the best-performing configurations we obtained for each dataset, leading to different loss coefficients. On HVM, λ=0.00191149 was calibrated on training data to make the weighted anatomical gradient norm approximately 10% of the SR gradient norm, then fixed. The clDice coefficient increased linearly to 0.5 over the first 400 updates. On MSD, the saved coefficients were anchor=1, Dice=1, clDice=0.5, and LPIPS=0.
The VQ-f4 reference is used only for the training perceptual loss. Evaluation LPIPS is computed against the corresponding HR image without VQ reconstruction. ROI LPIPS uses the same reference, with aggregation restricted to the specified region.
Inference starts with an initial SR reconstruction, followed by vessel segmentation, mask refinement and decoding, and SR reconstruction conditioned on the updated mask. Every SR round uses the original LR input.
We will release the code and detailed materials for reproducing our experiments after publication.